Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.20 +0.00 (+0.00%)
As of: Oct 21, 2026 · 3:59 PM EDT

Eloxx Pharmaceuticals (ELOX) Long-Term Debt Issuances (2017 - 2025)

Updated

Eloxx Pharmaceuticals (ELOX) posted Long-Term Debt Issuances of $2.87 million for FY2025, down 21.9% from $3.67 million in FY2024.

Analysis

Eloxx Pharmaceuticals (ELOX) Long-Term Debt Issuances (2017 - 2025) Analysis & Trends

Since FY2017, Eloxx Pharmaceuticals has reported Long-Term Debt Issuances for 6 years.

  • Annual Long-Term Debt Issuances shows a five-year compound annual growth rate of 29.2% (FY2020 to FY2025).
  • The FY2025 figure stands as the lowest annual Long-Term Debt Issuances since FY2020.
  • Business Quant data shows ELOX's Long-Term Debt Issuances at $3.67 million in FY2024 and $11.87 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Eloxx Pharmaceuticals 89.68 Mn 16.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.88 Mn
Mar 31, 2025 390,000.00
Dec 31, 2021 -36,000.00
Mar 31, 2019 15.00 Mn
Mar 31, 2017 2.46 Mn
API Access

Eloxx Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=ELOX&period=max&api_key=YOUR_API_KEY